Attached files

file filename
8-K - 8-K - NPS PHARMACEUTICALS INCa15-5111_18k.htm
EX-3.2 - EX-3.2 - NPS PHARMACEUTICALS INCa15-5111_1ex3d2.htm

Exhibit 3.1

 

AMENDED AND RESTATED

 

CERTIFICATE OF INCORPORATION

 

OF

 

NPS PHARMACEUTICALS, INC.

 

FIRST:  The name of the corporation is NPS Pharmaceuticals, Inc. (the “Corporation”).

 

SECOND:  The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, Delaware 19801.  The name of its registered agent at such address is The Corporation Trust Company.

 

THIRD:  The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended (the “DGCL”).

 

FOURTH:  The total number of shares of stock which the Corporation shall have authority to issue is 1,000, and the par value of each such share is $0.01, amounting in the aggregate to $10.00.

 

FIFTH:  The Board of Directors shall have the power to adopt, amend or repeal the bylaws of the Corporation.

 

SIXTH:  Election of directors need not be by written ballot unless the bylaws of the Corporation so provide.

 

SEVENTH:  The Corporation expressly elects not to be governed by Section 203 of the DGCL.

 

EIGHTH:  (1) A director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law (iii) under Section 174 of the DGCL, or (iv) for any transaction from which the director derived an improper personal benefit. If the DGCL is amended after approval by the stockholders of this ARTICLE EIGHTH to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.

 



 

(2) Any repeal or modification of this ARTICLE EIGHTH shall be prospective and shall not affect the rights under this ARTICLE EIGHTH in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification.

 

NINTH:  The Corporation reserves the right to amend this Certificate of Incorporation in any manner permitted by the DGCL and all rights and powers conferred herein on stockholders, directors and officers, if any, are subject to this reserved power.